Type 1 Diabetes Trial, Recruiting (NCT06646107)

Type 1 Diabetes Trial, Recruiting NCT06646107 Sponsor: Attikon Hospital Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06646107 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been clinically diagnosed with type 1 diabetes for more than 1 year before signing the consent form (the diagnosis is based on the doctor's judgment; special blood tests are not required).
People whose HbA1c (a measure of average blood sugar over time) is below 12.5%.
People who are older than 7 years of age at the time the system is started.
People who are currently managing their diabetes with multiple daily insulin injections (a basal-bolus approach), using more than 8 units of insulin per day on average over a week.
People who are medically suitable to begin using an automated insulin delivery system (confirm with trial site).
People who have had at least 3 clinic visits in the past year.

Who may not be able to join:

People who have had a serious diabetes complication called diabetic ketoacidosis (a dangerous build-up of acids in the blood) in the 6 months before the screening visit.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2105831148

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06646107

Sponsor: Attikon Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 2105831148

More information: https://clinicaltrials.gov/study/NCT06646107

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been clinically diagnosed with type 1 diabetes for more than 1 year before signing the consent form (the diagnosis is based on the doctor's judgment; special blood tests are not required).
People whose HbA1c (a measure of average blood sugar over time) is below 12.5%.
People who are older than 7 years of age at the time the system is started.
People who are currently managing their diabetes with multiple daily insulin injections (a basal-bolus approach), using more than 8 units of insulin per day on average over a week.
People who are medically suitable to begin using an automated insulin delivery system (confirm with trial site).
People who have had at least 3 clinic visits in the past year.

Who may not be able to join:

People who have had a serious diabetes complication called diabetic ketoacidosis (a dangerous build-up of acids in the blood) in the 6 months before the screening visit.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Attikon Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2025

Est. completion

31 August 2025

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Changes in Hba1c; Changes in TIR; Changes in TBR; Changes in TAR; Changes in bolus doses; Changes in basal doses; Changes in autocorrection doses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov